Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 1.2014

View More View Less
Restricted access

During the past few years, several genetic aberrations that may contribute to increased risks for development of breast and/or ovarian cancers have been identified. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast and Ovarian focus specifically on the assessment of genetic mutations in BRCA1/BRCA2, TP53, and PTEN, and recommend approaches to genetic testing/counseling and management strategies in individuals with these mutations. This portion of the NCCN Guidelines includes recommendations regarding diagnostic criteria and management of patients with Cowden Syndrome/PTEN hamartoma tumor syndrome.

  • 1.

    Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759767.

  • 2.

    Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993;9:138141.

  • 3.

    Lynch HT, Watson P, Conway TA, Lynch JF. Clinical/genetic features in hereditary breast cancer. Breast Cancer Res Treat 1990;15:6371.

  • 4.

    Pharoah PD, Day NE, Duffy S. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997;71:800809.

    • Search Google Scholar
    • Export Citation
  • 5.

    Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 2007;16:241260.

    • Search Google Scholar
    • Export Citation
  • 6.

    Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med 2008;359:21432153.

  • 7.

    Trepanier A, Ahrens M, McKinnon W. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns 2004;13:83114.

    • Search Google Scholar
    • Export Citation
  • 8.

    Pharoah PD, Antoniou A, Bobrow M. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002;31:3336.

  • 9.

    Orloff MS, Eng C. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 2008;27:53875397.

  • 10.

    Eng C. PTEN hamartoma tumor syndrome (PTHS). In: Pagon RA, Adam MP, Ardinger HH, eds. GeneReviews [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2014. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1488/. Accessed August 5, 2014.

    • Search Google Scholar
    • Export Citation
  • 11.

    Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns 2009;18:1327.

  • 12.

    Pilarski R, Stephens JA, Noss R. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011;48:505512.

    • Search Google Scholar
    • Export Citation
  • 13.

    Varga EA, Pastore M, Prior T. The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly. Genet Med 2009;11:111117.

    • Search Google Scholar
    • Export Citation
  • 14.

    Hobert JA, Eng C. PTEN hamartoma tumor syndrome: an overview. Genet Med 2009;11:687694.

  • 15.

    Lloyd KM 2nd, Dennis M. Cowden’s disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963;58:136142.

    • Search Google Scholar
    • Export Citation
  • 16.

    Nelen MR, Kremer H, Konings IB. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 1999;7:267273.

    • Search Google Scholar
    • Export Citation
  • 17.

    Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004;41:323326.

    • Search Google Scholar
    • Export Citation
  • 18.

    Starink TM, van der Veen JP, Arwert F. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986;29:222233.

  • 19.

    Riegert-Johnson DL, Gleeson FC, Roberts M. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010;8:6.

    • Search Google Scholar
    • Export Citation
  • 20.

    Tan MH, Mester JL, Ngeow J. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18:400407.

  • 21.

    Bubien V, Bonnet F, Brouste V. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet 2013;50:255263.

  • 22.

    Brownstein MH, Wolf M, Bikowski JB. Cowden’s disease: a cutaneous marker of breast cancer. Cancer 1978;41:23932398.

  • 23.

    Harach HR, Soubeyran I, Brown A. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 1999;3:331340.

  • 24.

    Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol 2007;4:492502.

  • 25.

    Black D, Bogomolniy F, Robson ME. Evaluation of germline PTEN mutations in endometrial cancer patients. Gynecol Oncol 2005;96:2124.

  • 26.

    Nelen MR, Padberg GW, Peeters EA. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996;13:114116.

  • 27.

    Schaffer JV, Kamino H, Witkiewicz A. Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol 2006;142:625632.

    • Search Google Scholar
    • Export Citation
  • 28.

    Jazaeri AA, Lu K, Schmandt R. Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Mol Carcinog 2003;36:5359.

    • Search Google Scholar
    • Export Citation
  • 29.

    Brownstein MH, Mehregan AH, Bikowski JB. The dermatopathology of Cowden’s syndrome. Br J Dermatol 1979;100:667673.

  • 30.

    Brownstein MH, Mehregan AH, Bilowski JB. Trichilemmomas in Cowden’s disease. JAMA 1977;238:26.

  • 31.

    Heald B, Mester J, Rybicki L. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010;139:19271933.

    • Search Google Scholar
    • Export Citation
  • 32.

    Al-Thihli K, Palma L, Marcus V. A case of Cowden’s syndrome presenting with gastric carcinomas and gastrointestinal polyposis. Nat Clin Pract Gastroenterol Hepatol 2009;6:184189.

    • Search Google Scholar
    • Export Citation
  • 33.

    Zhou XP, Waite KA, Pilarski R. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003;73:404411.

    • Search Google Scholar
    • Export Citation
  • 34.

    Andres RH, Guzman R, Weis J. Lhermitte-Duclos disease with atypical vascularization—case report and review of the literature. Clin Neuropathol 2009;28:8390.

    • Search Google Scholar
    • Export Citation
  • 35.

    Butler MG, Dasouki MJ, Zhou XP. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005;42:318321.

    • Search Google Scholar
    • Export Citation
  • 36.

    Herman GE, Butter E, Enrile B. Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. Am J Med Genet A 2007;143:589593.

    • Search Google Scholar
    • Export Citation
  • 37.

    Herman GE, Henninger N, Ratliff-Schaub K. Genetic testing in autism: how much is enough? Genet Med 2007;9:268274.

  • 38.

    Orrico A, Galli L, Buoni S. Novel PTEN mutations in neurodevelopmental disorders and macrocephaly. Clin Genet 2009;75:195198.

  • 39.

    Roche AF, Mukherjee D, Guo SM, Moore WM. Head circumference reference data: birth to 18 years. Pediatrics 1987;79:706712.

  • 40.

    Gorlin RJ, Cohen MM Jr, Condon LM, Burke BA. Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 1992;44:307314.

  • 41.

    Marsh DJ, Coulon V, Lunetta KL. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998;7:507515.

    • Search Google Scholar
    • Export Citation
  • 42.

    Tan MH, Mester J, Peterson C. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 2011;88:4256.

    • Search Google Scholar
    • Export Citation
  • 43.

    Eng C. Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000;37:828830.

  • 44.

    Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003;22:183198.

  • 45.

    Pilarski R, Burt R, Kohlman W. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 2013;105:16071616.

    • Search Google Scholar
    • Export Citation
  • 46.

    National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Thyroid Cancer. Available at: http://seer.cancer.gov/statfacts/html/thyro.html. Accessed August 5, 2014.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 465 346 14
PDF Downloads 132 89 5
EPUB Downloads 0 0 0